Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for COVID-19; This is a spontaneous report from contactable consumer (patient) via Pfizer sponsored program. A 40-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: FC3183) via an unspecified route of administration in arm left on 04Sep2021 16:00 as dose 1, single (age at vaccination: 40 years) for COVID-19 immunisation. Medical history included heart ablation from 2020 to 2020 This was done a year ago for SVT-supraventricular tachycardia because when she was pregnant with her last baby, she had all that so they decided to do the heart ablation after she had the baby, supraventricular tachycardia, anxiety, both from an unknown date and unknown if ongoing. Concomitant medications included clonazepam (KLONOPIN) 0.5 mg as needed taken for anxiety from an unspecified start date and ongoing; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) 7.5 mL, daily taken for an unspecified indication from an unspecified start date and ongoing; zinc (ZINC) 15mL liquid taken for an unspecified indication from an unspecified start date and ongoing; cholecalciferol (VITAMIN D [COLECALCIFEROL]) chewable gummy taken for an unspecified indication from an unspecified start date and ongoing. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect, all vaccines administered on same date with the Pfizer vaccine considered as suspect was none. Prior Vaccinations (within 4 weeks) any other vaccinations within four weeks prior to the first administration date of the suspect vaccines was none. The adverse events following prior vaccinations was none. Other relevant medical history including but not limited to these conditions: diagnosed allergies, compromised immune status, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity was none. The culture, serotyping was not performed. The predisposing factors (e.g., immunosuppression, contact with other infected persons) was son came home from school with COVID. No antipyretic was used (around the date(s) of Vaccination). On 09Sep2021 10:30, the patient experienced tested positive for COVID-19. Mom had COVID-saw how bad she struggled with it made her say she does not want to struggle like that. She heard if she gets vitamin-C, vitamin-D, zinc in COVID this will help her immune system. She explained that her son came home from school with COVID. She verified she had a couple of questions in terms of whether it is a good idea to get her second dose of Pfizer-BioNTech Covid-19 Vaccine within the 21 days, or if she should wait. She was scheduled for second dose on 25Sep2021. The adverse event did not result in emergency room/physician Office. The product complaint includes consumer is patient who was administered first dose of Pfizer-BioNTech Covid-19 Vaccine on 04Sep2021. On 09Sep2021 they tested positive for COVID-19 on COVID-19 nose swab test. Patient explained that their child came home from school with COVID. The patient underwent lab tests and procedures which included sars-cov-2 test resulted as positive for covid-19 on 09Sep2021 nose swab test. The clinical outcome of the event was unknown.